Cite
HARVARD Citation
Beiert, T. et al. (2018). Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties. International journal of cardiology. pp. 21-28. [Online].